NEURAL CREST TUMORS - I-123 METAIODOBENZYLGUANIDINE IMAGING IN CHILDREN

被引:39
作者
PALTIEL, HJ
GELFAND, MJ
ELGAZZAR, AH
WASHBURN, LC
HARRIS, RE
MASTERS, PR
GOLSCH, GJ
机构
[1] CHILDRENS HOSP MED CTR,DEPT RADIOL,CINCINNATI,OH 45229
[2] UNIV CINCINNATI,SCH MED,DEPT RADIOL,CINCINNATI,OH
[3] UNIV CINCINNATI,MED CTR,EL SAENGER RADIOISOTOPE LAB,CINCINNATI,OH 45267
[4] CHILDRENS HOSP MED CTR,DIV HEMATOL ONCOL,CINCINNATI,OH
关键词
IODINE AND IODINE COMPOUNDS; RADIOACTIVE; NEUROBLASTOMA; PHEOCHROMOCYTOMA;
D O I
10.1148/radiology.190.1.8259387
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine 24- and 48-hour distribution of iodine-123 metaiodobenzylguanidine (MIBG) and to establish an optimized pediatric imaging protocol. MATERIALS AND METHODS: Seventy-seven 1-123 MIBG scans obtained in 33 children undergoing evaluation for neural crest tumor were reviewed. RESULTS: Activity in the salivary glands, myocardium, liver, gut, and bladder was demonstrated on almost all scans. Activity was noted in the neck muscles, thyroid gland, and uninvolved adrenal gland in fewer studies. In 20 studies, abnormal uptake was present in the chest or abdomen at 24 and 48 hours, and lesion identification was improved at 48 hours in 12 studies. Detection of skeletal lesions on 14 scans was similar at 24 and 48 hours. Foci of tumor were first detected at 1-123 MIBG imaging in nine studies, and in only two patients was tumor involvement initially missed on 1-123 MIBG studies. CONCLUSION: Distribution of 1-123 MIBG on images in children differs from that in earlier descriptions in adults. Images of the torso at 48 hours after injection are a useful adjunct in detection of lesions.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 19 条
[1]   TREATMENT OF NEUROBLASTOMA WITH I-131 METAIODOBENZYLGUANIDINE - DOSIMETRIC PROBLEMS AND PERSPECTIVES [J].
BEIERWALTES, WH .
MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (04) :188-191
[2]  
BOMANJI J, 1987, J NUCL MED, V28, P973
[3]  
BOMANJI J, 1987, J NUCL MED, V28, P319
[4]   METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) LABELED WITH I-123/I-131 IN NEUROBLASTOMA DIAGNOSIS AND FOLLOW-UP TREATMENT WITH A REVIEW OF THE DIAGNOSTIC RESULTS OF THE INTERNATIONAL WORKSHOP OF PEDIATRIC ONCOLOGY HELD IN ROME, SEPTEMBER 1986 [J].
FEINE, U ;
MULLERSCHAUENBURG, W ;
TREUNER, J ;
KLINGEBIEL, T .
MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (04) :181-187
[5]  
Geatti O, 1988, Am J Physiol Imaging, V3, P188
[6]  
GELFAND MJ, 1986, J NUCL MED, V27, P1800
[7]  
GORDON I, 1990, J NUCL MED, V31, P129
[8]  
HOEFNAGEL CA, 1987, J NUCL MED, V28, P308
[9]   CONSOLIDATING THE ROLE OF STAR-I-MIBG-SCINTIGRAPHY IN CHILDHOOD NEUROBLASTOMA - 5 YEARS OF CLINICAL-EXPERIENCE [J].
JACOBS, A ;
DELREE, M ;
DESPRECHINS, B ;
OTTEN, J ;
FERSTER, A ;
JONCKHEER, MH ;
MERTENS, J ;
HAM, HR ;
PIEPSZ, A .
PEDIATRIC RADIOLOGY, 1990, 20 (03) :157-159
[10]  
Jacques Jr S, 1984, MOL PHARMACOL, V26, P539